Upperton Pharma Solutions Revenue and Competitors
Estimated Revenue & Valuation
- Upperton Pharma Solutions's estimated annual revenue is currently $18.3M per year.
- Upperton Pharma Solutions's estimated revenue per employee is $155,000
Employee Data
- Upperton Pharma Solutions has 118 Employees.
- Upperton Pharma Solutions grew their employee count by 13% last year.
Upperton Pharma Solutions's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Founder & CSO | Reveal Email/Phone |
4 | Financial Officer | Reveal Email/Phone |
5 | Head Business Operations | Reveal Email/Phone |
6 | Head Analytical Development | Reveal Email/Phone |
7 | Associate Director, Manufacturing Operations | Reveal Email/Phone |
8 | Director Pharmaceutical Sciences | Reveal Email/Phone |
9 | Director Clinical Manufacturing | Reveal Email/Phone |
10 | Director Analytical Services | Reveal Email/Phone |
Upperton Pharma Solutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.3M | 118 | 13% | N/A | N/A |
What Is Upperton Pharma Solutions?
Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing. We are able to enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular we have world leading expertise and know-how in pharmaceutical spray dryings, probably the most versatile and fastest growing technology in the industry. We have experience of working with a range of dosage forms and the expertise to develop the most challenging of molecules. Our formulation work is supported by a comprehensive range of analytical services for product testing and ICH stability studies. Upperton has an extensive, multinational client-base, ranging from virtual and small start-ups to global pharma companies. We pride ourselves on our client-focused, flexible approach and scientific excellence.
keywords:N/AN/A
Total Funding
118
Number of Employees
$18.3M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.8M | 121 | 42% | N/A |
#2 | $7.5M | 121 | 22% | N/A |
#3 | $17.1M | 122 | 24% | N/A |
#4 | $12.2M | 122 | 42% | N/A |
#5 | $25.6M | 122 | -50% | N/A |